Cosmos Health's Subsidiary Cana Laboratories Secures Additional Contract Manufacturing Agreements With Provident Pharmaceuticals; Provident Focuses On Niche And Legacy Pharmaceutical Products And Medical Devices
Portfolio Pulse from Benzinga Newsdesk
Cosmos Health's subsidiary, Cana Laboratories, has secured additional contract manufacturing agreements with Provident Pharmaceuticals. The agreements include orders for MIOREL, CALCIFOLIN, and DEXA-DOSE, which are used for muscle spasms, nucleic acid synthesis, and anti-inflammatory purposes, respectively.
July 18, 2024 | 8:32 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cosmos Health's subsidiary, Cana Laboratories, has secured new manufacturing agreements with Provident Pharmaceuticals for three medicines: MIOREL, CALCIFOLIN, and DEXA-DOSE. This development is likely to boost Cosmos Health's revenue and market position in the pharmaceutical sector.
The new manufacturing agreements with Provident Pharmaceuticals are likely to increase Cosmos Health's revenue and strengthen its market position. The production of MIOREL, CALCIFOLIN, and DEXA-DOSE will likely contribute positively to the company's financial performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100